PDS Biotechnology(PDSB) - 2023 Q3 - Earnings Call Transcript

Conference Call Participants Nicole Jones Before we begin, we need to remind everyone that on todayÂ's call, the company will be making forwardlooking statements regarding regulatory and clinical candidate development plans, as well as research activities. Certain information in this presentation may include forward-looking statements, including within the meaning of Section 21(e) of the United States Securities Exchange Act of 1934, as amended, and Section 27(a) of the United States Securities Act of 1933, ...